Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-03
2006-10-03
Woitach, Joseph (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C435S325000
Reexamination Certificate
active
07115724
ABSTRACT:
The present invention particularly relates to a newly identified murine genomic polynucleotide that encodes an ortholog of the human P2T receptor which is expressed at high levels in the central nervous system, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. The invention relates also to identifying compounds which may be agonists, antagonists and/or inhibitors of P2T, and therefore potentially useful in therapy.
REFERENCES:
patent: 6060272 (2000-05-01), Li et al.
Adachi, J., et al., “Functional annotation of a full-length mouse cDNA collection”,Nature409, 865-690, 2001.
Boeynaems et al., “P2Y receptors: in the middle of the road,”TIPS 21, 1-3, 2000.
Boyer et al., “Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase,”J Pharmacol Exp Ther. 267, 1140-1146, 1993.
Cattaneo et al., “Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate,”Blood 80, 2787-2796, 1992.
Chambers et al., “A G protein-coupled receptor for UDP-glucose ,”J. Biol. Chem. 275, 10767-71, 2000.
Chen and Chen, ATP-induced arachadonic acid release in cultured astrocytes is mediated by Gi protein coupled P2Y1 and P2Y2 receptors,Glia22, 360-370, 1998.
Harder et al, “P2-purinergic receptors,”Annu. Rev. Pharmacol. Toxicol. 35, 541-579, 1995.
Hoffmann et al., “The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes,”J Biol Chem. 274, 14639-47, 1999.
Hollopeter et al., “Identification of the platelet ADP receptor targeted by antithrombotic drugs,”Nature409, 202-207, 2001.
Jacobs et al., “A genetic selection for isolating cDNAs encoding secreted proteins,”Gene198, 289-296, 1997.
Jantzen et al., “Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation,”Thromb Haemost81, 111-117, 1999.
Jiang et al., “A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor,”Mol Pharmacol. 52, 499-507, 1997.
Kunapuli, “Multiple P2 receptor subtypes on platelets: a new interpretation of their function,”TIPS 19, 391-394, 1998.
Mumberg et al., “Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds,”Gene 156, 119-122, 1995.
Nurden et al., “An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets,”J. Clin. Invest. 95, 1612-1622, 1995.
Pausch et al., Heterologous G Protein-Coupled Receptors Expressed inSaccharomyces cerevisiae: Methods for Genetic Analysis and Ligand Identification.In“Identification and Expression of G Protein-Coupled Receptors.” (Ed, L, R. Lynch) “Receptor Biochemistry and Methodology” (Series Eds. Sibley, D. and Strader, C.), pp. 196-212, Wiley, Inc., 1998.
Pausch, “GPCRs inSaccharomyces cerevisiae: HTS assays for drug discovery,”TIB 15, 48-494, 1997.
Robinson and Dowd, “Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system,”Adv. Pharmacology 37, 69-115, 1997.
Webb et al., “The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase,”Br. J. Pharmacol. 119, 1385-1392, 1996.
Zhang et al., “ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999,”J. Biol. Chem., 276:8608-8615, 2001.
Leon, C. et al. Defective Platelet Aggregation and Increased Resistance to Thrombosis in Purinergic P2YI Receptor-Null Mice,Journal of Clinical Investigation. Dec. 1999, vol. 104, No. 12, pp. 1731-1737.
Enjyoji, K. et al. Targeted Disruption of cd39/ATP Diphosphorylase Results in Disordered Hemostatsis and Thromboregulation.Nature Medicine. Sep. 1999, vol. 5, No. 9, pp. 1010-1017.
Leon, C. et al. The P2Y1 Receptor is Normal in a Patient Presenting a Severe Deficiency of ADP-Induced Platelet Aggregation.Thrombosis and Hemostasis. 1999. vol. 81, No. 5, pp. 775-781.
Sun, B. et al. P2X1 Purinoceptor in Human Platelets.Journal of Biological Chemistry. May 8, 1998, vol. 273, No. 19, pp. 11544-11547.
Jin, J. et al. Molecular Basis for ADP-Induced Platelet Aggregation.Journal of Biological Chemistry. Jan. 23, 1998, vol. 273, No. 4, pp. 2030-2034.
Cattaneo, M. et al. ADP Receptors and Clinical Bleeding Disorders.Arterosclerosis Thrombosis and Vascular Biology. Oct. 1999. vol. 19, pp. 2281-2285.
Bittendender Teresa O.
Woitach Joseph
Wyeth
Wyeth
LandOfFree
Murine genomic polynucleotide sequence encoding a G-protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Murine genomic polynucleotide sequence encoding a G-protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Murine genomic polynucleotide sequence encoding a G-protein... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3658058